PIK3CA mutations and first-line outcomes in endocrine-resistant HR+/HER2- metastatic breast cancer: A multicentric real-world study.
Saved in:
| Title: | PIK3CA mutations and first-line outcomes in endocrine-resistant HR+/HER2- metastatic breast cancer: A multicentric real-world study. |
|---|---|
| Authors: | Dieci MV; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy. Electronic address: mariavittoria.dieci@unipd.it., Vernaci G; Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy., Colangelo C; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy; Basic and Translational Oncology, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy; Functional Proteomic Section, Department of Life Sciences, University of Siena, Siena 53100, Italy., Bria E; University Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy; Ospedale Isola Tiberina - Gemelli Isola, Rome, Italy., Massa D; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy., Di Liso E; Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy., Giorgi CA; Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy., Giarratano T; Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy., Napetti D; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy., Bonomi G; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy., Zanghì F; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy., Bottosso M; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy., Lazzarini E; Basic and Translational Oncology, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy., Santarelli L; Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy; Basic and Translational Oncology, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy., Boscolo Bragadin A; Basic and Translational Oncology, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy., Indraccolo S; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Basic and Translational Oncology, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy., Guarneri V; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy. |
| Source: | European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2026 Feb 05; Vol. 234, pp. 116194. Date of Electronic Publication: 2025 Dec 19. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
